awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q46801651-CF53CE47-4474-4FE3-A3E5-F869C3751EC4
Q46801651-CF53CE47-4474-4FE3-A3E5-F869C3751EC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46801651-CF53CE47-4474-4FE3-A3E5-F869C3751EC4
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemia.
P2860
Q46801651-CF53CE47-4474-4FE3-A3E5-F869C3751EC4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46801651-CF53CE47-4474-4FE3-A3E5-F869C3751EC4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30676d0cc9c3e26e84bfc7a99bcb02f9d2a8052a
P2860
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.